Lunaphore

Developer of microfluidic-based instruments for tumor analysis

placeMorges, Vaud, Switzerland calendar_todayFounded 2014 groups133 employees language lunaphore.com

Social engagement

Social engagement: 25.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include PHC Holdings, Redalpine, Ernst Göhner; 3 have since exited.

Investor typeCountShare
Venture capital440%
Private equity110%
Bank & private debt110%
Other / undisclosed440%

Recent activity

4 May 2026
Expansion
Lunaphore and Advanced Cell Diagnostics (ACD)
16 Apr 2026
Product launch
Bio-Techne SpatialTM
14 Apr 2026
Event
AACR Annual Meeting
Coming soon